Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Croucher PI, Shipman CM, Lippitt J, Perry M, Asosingh K, Hijzen A, Brabbs AC, van Beek EJ, Holen I, Skerry TM, Dunstan CR, Russell GR, Van Camp B, Vanderkerken K.
Croucher PI, et al. Among authors: perry m.
Blood. 2001 Dec 15;98(13):3534-40. doi: 10.1182/blood.v98.13.3534.
Blood. 2001.
PMID: 11739154
Free article.